[go: up one dir, main page]

AU7540598A - Contrast media - Google Patents

Contrast media

Info

Publication number
AU7540598A
AU7540598A AU75405/98A AU7540598A AU7540598A AU 7540598 A AU7540598 A AU 7540598A AU 75405/98 A AU75405/98 A AU 75405/98A AU 7540598 A AU7540598 A AU 7540598A AU 7540598 A AU7540598 A AU 7540598A
Authority
AU
Australia
Prior art keywords
contrast media
contrast
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75405/98A
Inventor
Edward Richard Bacon
Julian Cockbain
Patrick Joseph Hayley
Gregory Lynn Mcintire
John Luke Toner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of AU7540598A publication Critical patent/AU7540598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • A61K49/0485—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1815—Suspensions, emulsions, colloids, dispersions compo-inhalant, e.g. breath tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU75405/98A 1997-05-22 1998-05-22 Contrast media Abandoned AU7540598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9710604 1997-05-22
GBGB9710604.1A GB9710604D0 (en) 1997-05-22 1997-05-22 Contrast media
PCT/GB1998/001489 WO1998052617A2 (en) 1997-05-22 1998-05-22 Contrast media for imaging of lung draining lymph nodes, administered through the lungs

Publications (1)

Publication Number Publication Date
AU7540598A true AU7540598A (en) 1998-12-11

Family

ID=10812900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75405/98A Abandoned AU7540598A (en) 1997-05-22 1998-05-22 Contrast media

Country Status (5)

Country Link
EP (1) EP0975372A1 (en)
JP (1) JP2001525846A (en)
AU (1) AU7540598A (en)
GB (1) GB9710604D0 (en)
WO (1) WO1998052617A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69534233T2 (en) 1994-09-16 2005-10-27 Ethicon Endo-Surgery, Inc., Cincinnati DEVICES FOR DETERMINING AND MARKING TISSUE
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
GB0123013D0 (en) * 2001-09-25 2001-11-14 Upperton Ltd Improvements relating to imaging contrast agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911690A (en) * 1985-03-29 1990-03-27 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Treatment or diagnosis by endoscopic administration into the lymphatics
FR2644059B1 (en) * 1989-03-08 1994-03-04 Fabre Medicament Pierre AEROSOL COMPOSITIONS FOR IMAGING, DIAGNOSIS AND TARGETED THERAPY OF INFLAMMATORY AND TUMOR FIREPLACES
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
NZ248650A (en) * 1992-12-15 1994-08-26 Sterling Winthrop Inc Diagnostic image enhancing void-containing organic particle; preparation by co-precipitation of two organic substances and leaching out one of them
US5525328A (en) * 1994-06-24 1996-06-11 Nanosystems L.L.C. Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging
AU4990696A (en) * 1995-02-24 1996-09-11 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
EP0862420A4 (en) * 1995-10-13 1999-11-03 Penn State Res Found Synthesis of drug nanoparticles by spray drying

Also Published As

Publication number Publication date
WO1998052617A2 (en) 1998-11-26
WO1998052617A3 (en) 1999-08-12
EP0975372A1 (en) 2000-02-02
GB9710604D0 (en) 1997-07-16
JP2001525846A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU1885297A (en) Contrast medium
AU5272198A (en) EMP-charge-eliminator
AU6998698A (en) Dioxacycloalkan-8-one
AU4117497A (en) Micropolarimeter
AU6185898A (en) Clavaspirins
AU9204598A (en) Roller-inserter associated with media cartridge
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU7540598A (en) Contrast media
AU1452397A (en) Contrast media
AU6858898A (en) Media vehicle
AU6119498A (en) X-ray contrast media
AU5391798A (en) Thiamacrolides
AU4469997A (en) Heregulin-gamma
AU9183798A (en) Catamaran - bicycle - kayak
AU8991998A (en) Renovative pipeliner
AU8546598A (en) Cartridge
AU5540298A (en) Rockbolts
AU3839199A (en) Contrast media